X0306 4 2013-12-06 0 0001178711 Transcept Pharmaceuticals Inc TSPT 0001331693 Roumell Asset Management, LLC 2 WISCONSIN CIR SUITE 660 CHEVY CHASE MD 20815 0 0 1 0 Common Stock 2013-12-06 2013-12-06 4 S 0 8710 3.5406 D 1896981 I FN Common Stock 2013-12-09 2013-12-09 4 J 0 2030 0 D 1894951 I FN Common Stock 300000 I FN Common Stock 24490 D Sales required to accomodate client-requested account liquidation. Client requested account transfer to another investment advisor and/or brokerage firm. Represents shares of common stock deemed to be owned beneficially by Roumell Asset Management, LLC ("RAM") solely as a result of its discretionary power over such shares as investment adviser to its clients. Represents shares of common stock deemed to be owned beneficially by RAM solely as a result of its discretionary power over such shares as investment adviser to the Roumell Opportunistic Value Fund (the "Fund"). Represents shares held by Mr. Roumell. Mr. Roumell is President of RAM and holds a controlling percentage of its outstanding voting securities and, as a result of his position with and ownership of securities of RAM, Roumell could be deemed the beneficial of the shares beneficially owned by RAM and those held by the Fund. Mr. Roumell disclaims beneficial ownership of shares owned by RAM and the Fund except to the extent of his pecuniary interest in such shares. /s/ James C. Roumell, in his individual capacity and as President of RAM 2013-12-10